0.00Open0.00Pre Close0 Volume0 Open Interest0.50Strike Price0.00Turnover0.00%IV-44.13%PremiumJul 19, 2024Expiry Date0.40Intrinsic Value100Multiplier6DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.83Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Kazia Therapeutics Stock Discussion
The $Dow Jones Industrial Average(.DJI.US)$surged to a new record, closing up 247.15 points (0.62%) at 40,000.90. The $S&P 500 Index(.SPX.US)$ and $Nasdaq Composite Index(.IXIC.US)$ also saw gains of 0.55% and 0.63% respectively. This rally was driven by positive investor sentiment despite mixed economic signals.
Key Stock Movements
• eVTOL Stocks: $Joby Aviation(JOBY.US)$ soared nearly 28% and $Archer Aviation(ACHR.US)$ rose over...
Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, has recently announced findings from a Phase II/III clinical trial evaluating their novel drug, paxalisib, for the treatment of glioblastoma. Glioblastoma is a highly aggressive and life-threatening brain cancer, representing one of th...
No comment yet